`

OncoSec

Biotechnology Research

Specialities :
Oncology
Cancer treatment
Drug development
Immunotherapy
Life sciences

+1

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About OncoSec

What does Oncosec do?+

OncoSec is a biotechnology company pioneering new technologies to stimulate the bodys immune system to target and attack cancer. Through its proprietary DNA gene transfer technology, OncoSec seeks to deliver safer and more effective cancer treatments that can provide long-term benefits for patients who have limited or no available treatment options. OncoSecs technology combines TAVOTM (tavokinogene telseplasmid), an intratumoral (IT) DNA plasmid-based interleukin-12 (IL-12) designed to achieve targeted and sustained delivery of IT IL-12. TAVO has demonstrated a local and systemic anti-tumor response in several clinical trials, including preliminary data in a registration directed Phase 2b trial KEYNOTE-695 for anti-PD-1...

What are Oncosec's specialties? +

Oncology,cancer treatment,drug development,immunotherapy,life sciences,and clinical development

What is Oncosec's industry? +

Oncosec operates in the Biotechnology research industry.

What is Oncosec's revenue? +

Oncosec's revenue is 11m - 100m

What is Oncosec's company size? +

Oncosec has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.